Osteoarthritis Market Trends, Key Players Analysis, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Osteoarthritis Market covers analysis by Treatment (Drugs, Assistive Devices); Disease (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis); End User (Hospital Pharmacies, Retail pharmacies, Drug Stores, E-commerce.), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00004594
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

The Osteoarthritis Market is expected to register a CAGR of 8.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Osteoarthritis Market report covers analysis by Treatment (Drugs, Assistive Devices); Disease (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis); End User (Hospital Pharmacies, Retail pharmacies, Drug Stores, E-commerce.), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Osteoarthritis Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Osteoarthritis Market Segmentation

Treatment

  • Drugs
  • Assistive Devices

Disease

  • Knee Osteoarthritis
  • Spine Osteoarthritis
  • Foot and Ankle Osteoarthritis
  • Shoulder Osteoarthritis
  • Hand Osteoarthritis

End User

  • Hospital Pharmacies
  • Retail pharmacies
  • Drug Stores
  • E-commerce

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Osteoarthritis Market: Strategic Insights

osteoarthritis-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Osteoarthritis Market Growth Drivers

  • Increasing elderly population: The aging population around the world drives the osteoarthritis market. The likelihood of osteoarthritis, a degenerative joint disease, grows significantly as the lifespan of an individual increases. Older adults are more vulnerable to conditions such as osteoarthritis, which primarily affects the weight-bearing joints of the body, including the knees, hips, and spine. This is contributing to the increase in demand for osteoarthritis treatments such as drugs, therapies, and surgery.
  • Growing prevalence of obesity: Obesity is one of the major risk factors for osteoarthritis, especially in the knee joints. The increasing prevalence of obesity worldwide due to sedentary lifestyles, poor dietary habits, and limited physical activity is contributing to the increase in osteoarthritis cases. Excess body weight puts additional stress on joints, which worsens the condition. As the rate of obesity continues to rise, the demand for osteoarthritis treatments will also increase.
  • Advancements in treatment options: Advances in medical research and technology have led to the development of new and more effective treatment options for osteoarthritis. These include targeted biologic therapies, regenerative treatments like platelet-rich plasma (PRP) and stem cell therapy, and novel drug formulations that can help manage symptoms more effectively. As these treatments become more available and accessible, they will likely drive the market growth.

Osteoarthritis Market Future Trends

  • Shift toward non-surgical treatments: There is a growing trend toward non-surgical treatments for osteoarthritis, as many patients prefer non-invasive approaches that can relieve symptoms without the need for joint replacement surgery. Non-pharmacological options such as physical therapy, weight management programs, and lifestyle changes are becoming more popular, along with injectable treatments like hyaluronic acid, corticosteroids, and biologics. This trend is likely to continue, as many patients seek to avoid the risks and long recovery times associated with surgery.
  • Increasing adoption of biologics and regenerative therapies: The biologics and regenerative therapies include stem cell injections, PRP therapy, and gene therapies. These are used to treat osteoarthritis and focus on repairing or regenerating damaged cartilage and joints. Biologic treatments can provide an alternative to drugs and surgeries. With more and more clinical evidence proving the efficacy and safety of these treatments, the adoption of biologic treatments is expected to grow rapidly and will be the major growth driver for the osteoarthritis market.
  • Increase in demand for customized therapies: Personalized or precision medicine is becoming increasingly popular in the treatment of osteoarthritis, emphasizing tailoring therapy according to individual genetic profile, disease progression, and specific needs. Advancements in genomics, biomarkers, and diagnostics can help healthcare service providers provide more targeted treatment to patients with osteoarthritis. With this customization, patients are expected to experience better outcomes and drive market demand.

Osteoarthritis Market Opportunities

  • Development of disease-modifying osteoarthritis drugs (DMOADs): Today, the primary thrust in osteoarthritis therapy remains symptomatic treatment, that is, managing the symptoms by relieving pain and inflammation. Still, an area of major potential is that of disease-modifying osteoarthritis drugs, or DMOADs, which slow down or halt disease progression, by addressing the etiology of cartilage loss. Development and marketing of such a drug would radically alter the face of osteoarthritis therapy, provide sustained long-term benefits for patients, and propel growth in the market.
  • Research and development collaborative partnerships: Collaborations between pharmaceutical companies, research institutions, and biotechnology firms will be the future breakthroughs in osteoarthritis treatment. The pooling of resources and expertise will help accelerate the development of innovative therapies, including biologics, gene therapies, and new drug candidates. This also opens avenues for increasing the global reach of osteoarthritis treatments, which will enhance the growth potential of the market.
  • Over-The-Counter (OTC) osteoarthritis pain relief: The increasing preference for OTC solutions to manage osteoarthritis symptoms, such as pain and inflammation, represents a growing opportunity in the market. Products like topical analgesics, NSAIDs, and natural supplements are becoming more widely available without prescription. As patients seek convenient, cost-effective treatment options, the OTC segment of the osteoarthritis market is poised for growth.

Osteoarthritis Market Regional Insights

The regional trends and factors influencing the Osteoarthritis Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Osteoarthritis Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Osteoarthritis Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 8.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Treatment
  • Drugs
  • Assistive Devices
By Disease
  • Knee Osteoarthritis
  • Spine Osteoarthritis
  • Foot and Ankle Osteoarthritis
  • Shoulder Osteoarthritis
  • Hand Osteoarthritis
By End User
  • Hospital Pharmacies
  • Retail pharmacies
  • Drug Stores
  • E-commerce
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Novartis AG
  • Pfizer, Inc
  • Abiogen Pharma Spa
  • Ampio Pharmaceuticals
  • BioDelivery Sciences International, Inc
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Sanofi SA

  • Osteoarthritis Market Players Density: Understanding Its Impact on Business Dynamics

    The Osteoarthritis Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    osteoarthritis-market-cagr

    • Get the Osteoarthritis Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Osteoarthritis Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Osteoarthritis Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What are the major driving factors impacting the Osteoarthritis Market?
    The major factors driving the Osteoarthritis Market are Increasing elderly population, Growing prevalence of obesity, and Advancements in treatment options
    2
    What are the future trends of the Osteoarthritis Market?
    The key future trends of the market are Shift toward non-surgical treatments, Increasing adoption of biologics and regenerative therapies, and Increase in demand for customized therapies
    3
    Which are the leading players operating in the Osteoarthritis Market?
    The leading players operating in the Osteoarthritis Market include Abbott Laboratories, Novartis AG, Pfizer, Inc, Abiogen Pharma Spa, Ampio Pharmaceuticals, BioDelivery Sciences International, Inc, Eli Lilly and Company, GlaxoSmithKline plc., Sanofi SA.
    4
    What are the deliverable formats of Osteoarthritis Market report?
    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
    5
    What are the options available for the customization of this report?
    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
    6
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can't access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    - Abbott Laboratories
    - Novartis AG
    - Pfizer, Inc
    - Abiogen Pharma Spa
    - Ampio Pharmaceuticals
    - BioDelivery Sciences International, Inc
    - Eli Lilly and Company
    - GlaxoSmithKline plc.
    - Sanofi SA
    - Stryker Corporation
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo